logo

For the Inventor, By the Inventor

Machida, Japan

Shinji Tomioka

This inventor holds 7 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1977-1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Tomioka. Retrieved from https://idiyas.com/inventor/shinji-tomioka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 49(Granted Patents)


Location History:

  • Machida, JA (1977 - 1978)
  • Machida, JP (1978 - 1980)

Company Filing History:

goldMedal7 out of 4,189 
 
Abbott Laboratories Corporation
 patents

Years Active: 1977-1980

Loading Chart...
7 patents (USPTO):Explore Patents
1. 4218562 - Antibiotic derivatives of XK-62-2 (1980-08-19),
2. 4195171 - Derivatives of an antibiotic XK-62-2 and process for the production (1980-03-25),
3. 4132846 - 1-N-(.alpha.-Hydroxy-.beta.-aminopropionyl) XK-62-2 and method of (1979-01-02),
4. 4109077 - Antibiotic derivatives of XK-62-2 compounds (1978-08-22),
5. 4097664 - Derivatives of an antibiotic XK-62-2 (1978-06-27),
6. 4076931 - Derivatives of an antibiotic XK-62-2 and the process for the production (1978-02-28),
7. 4055715 - Method of producing (1977-10-25),

Title: The Innovations of Shinji Tomioka

Introduction

Shinji Tomioka is a prominent inventor based in Machida, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic derivatives. With a total of 7 patents to his name, Tomioka's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Tomioka has developed antibiotic derivatives of XK-62-2. These derivatives are prepared by chemically modifying the antibiotic XK-62-2. One notable example is 1-N-[L-(-)-α-hydroxy-γ-aminobutyryl]XK-62-2. Additionally, he has disclosed new 3'-N-demethyl- and 3'-N, 6'-N-didemethyl-1-α-hydroxy-ω-aminoacyl derivatives of the antibiotic XK-62-2, along with their pharmaceutically-acceptable acid addition salts and a process for preparing them.

Career Highlights

Shinji Tomioka is currently associated with Abbott Laboratories Corporation, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing antibiotic treatments and improving patient outcomes.

Collaborations

Throughout his career, Tomioka has collaborated with notable colleagues, including Yasuki Mori and Kunikatsu Shirahata. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Shinji Tomioka's contributions to antibiotic research and development exemplify the importance of innovation in the medical field. His patents and collaborations reflect a commitment to improving healthcare through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…